Navigation Links
GlaxoSmithKline Completes Acquisition of Stiefel
Date:7/22/2009

RESEARCH TRIANGLE PARK, N.C., July 22 /PRNewswire-FirstCall/ -- GlaxoSmithKline plc (GSK) (NYSE: GSK) today announced that it has completed its acquisition of Stiefel Laboratories, Inc. GSK has acquired the total share capital of Stiefel for a cash consideration of $2.9 billion. GSK also assumed $0.4 billion of net debt. Under the terms of the agreement, GSK may be obligated to make additional cash payments of up to $0.3 billion depending on the future performance of the business. The new dermatology business unit within GSK will operate under the name Stiefel, a GSK company.

Deirdre Connelly, President, North American Pharmaceuticals, GSK said, "The Stiefel acquisition demonstrates how we are implementing our strategy to grow and diversify our business through targeted acquisitions. We now have established a new world-leading, specialist dermatology business that will immediately generate new revenue flows to GSK."

Charles Stiefel, Chairman of Stiefel, said, "As part of GSK, we are stronger, more competitive and continue to be a driving force in dermatology around the world. We are excited to combine GSK's prescription dermatology products, such as Bactroban, Cutivate and Altabax, with Stiefel's portfolio, including brands such as Duac, Olux E and Soriatane. This combined portfolio, together with our specialty sales force and GSK's global presence, positions GSK's dermatology business for significant growth."

Sales of Stiefel's products for 2008 were approximately $900 million and sales of GSK's prescription dermatology products were approximately $550 million. The combined pro forma revenues of approximately $1.5 billion, represent an 8% share of the glo
'/>"/>

SOURCE GlaxoSmithKline plc
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. GlaxoSmithKline and Stiefel to Create New World-Leading Specialist Dermatology Business
2. Shire and GlaxoSmithKline Enter Agreement to Co-promote VYVANSE(R) (lisdexamfetamine dimesylate) CII for the Treatment of Adults With ADHD
3. Human Genome Sciences to Receive $9 Million Milestone Payment Related to GlaxoSmithKline Initiation of Phase 3 Clinical Trial of Syncria(R) in Type 2 Diabetes
4. GlaxoSmithKline Reports Q4 and Year End Results 2008
5. GlaxoSmithKline Successfully Completes Tender Offer for Shares of Genelabs Technologies, Inc.
6. GlaxoSmithKline Reduces Minimum Tender Condition and Extends Tender Offer To Acquire Genelabs Technologies, Inc.
7. AUDIO from Medialink and GlaxoSmithKline: FDA Approves Boostrix for Adults
8. GlaxoSmithKline Extends Tender Offer for Genelabs Technologies, Inc.
9. BioWa Licenses POTELLIGENT(R) Technology to GlaxoSmithKline for Use in Antibody Development and Commercialization
10. GlaxoSmithKline Announces Waiver of a Condition to the Tender Offer for Genelabs Technologies, Inc.
11. GlaxoSmithKline Commences Tender Offer to Acquire Genelabs Technologies, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... September 17, 2014 Beckman Coulter ... science and healthcare, has renewed its agreement with ... part of the agreement, Personify will continue to streamline ... emphasis on recruitment analytics, including time-to-fill, time-to-source and a ... our agreement with Personify was based on the success ...
(Date:9/17/2014)... The Pistoia Alliance, a global ... barriers to innovation in life sciences R&D through ... Nitsche as Executive Director Business Development North America, ... reach. , Carmen joins the Pistoia Alliance from ... At Accelrys, she managed various life sciences and ...
(Date:9/16/2014)... from jaw movements has been created by a group ... the device can generate electricity from eating, chewing and ... wearable electronic devices, such as hearing aids, cochlear implants, ... results of the device,s performance have been published today, ... and Structures . , Jaw movements have proved to ...
(Date:9/16/2014)... Rice University scientists who created a deicing film for ... as a transparent coating for glass. , The ... colleagues could keep glass surfaces from windshields to skyscrapers ... to radio frequencies (RF). , The technology was ... Applied Materials and Interfaces . , The ...
Breaking Biology Technology:Beckman Coulter Signs 3-year RPO Contract with Personify 2Beckman Coulter Signs 3-year RPO Contract with Personify 3Pistoia Alliance Expands Business Development with Appointment of Carmen Nitsche 2'Smart material' chin strap harvests energy from chewing 2Nanoribbon film keeps glass ice-free 2
... New, freely ... capture system , ... MA (PRWEB) May 10, 2010 -- Akaza Research announces the availability of the OpenClinica ... helps OpenClinica users find, share, and re-use clinical trial case report forms. It contains a ...
... GUANGZHOU, China , May 10 /PRNewswire-Asia/ -- China Medicine ... China of Western pharmaceuticals, traditional Chinese medicine,products, other nutraceuticals, medical devices, ... 9:00 a.m. Eastern,Time on Thursday, May 13, 2010 ... , , ...
... May 10 Fate Therapeutics, Inc. ... vice president of research and drug discovery.  Dr. Novak brings ... large pharmaceutical companies, including Roche and Wyeth, to apply transformative ... Novak will be responsible for Fate,s drug discovery and development ...
Cached Biology Technology:OpenClinica Case Report Form Library Now Available 2OpenClinica Case Report Form Library Now Available 3OpenClinica Case Report Form Library Now Available 4China Medicine Announces Conference Call to Discuss First Quarter 2010 Results 2Fate Therapeutics Appoints Tom Novak, Ph.D., as Vice President of Research and Drug Discovery 2Fate Therapeutics Appoints Tom Novak, Ph.D., as Vice President of Research and Drug Discovery 3
(Date:9/17/2014)... Campaigns against disposable plastic shopping bags and their environmental ... lawmakers passed the first statewide ban on the bags, ... But the plastic bag industry is not yielding without ... & Engineering News , the weekly newsmagazine of the ... with C&EN, reports that the anti-bag campaign logged its ...
(Date:9/17/2014)... Oncology-Bellvitge Biomedical Research Institute (ICO-IDIBELL), led by David ... normal accompanying cells in colorectal tumors. Analysis of ... tumors, predict the evolution of the patient and ... , Biomarkers , Colorectal cancer ... both sexes. About 30,000 new cases are diagnosed ...
(Date:9/17/2014)... [Brown University] After decades of decline, grasses have ... To the eye, the marsh in those places seems ... a key service of the marsh coastal protection ... but the ecosystem function hasn,t come back," said ecologist ... author of the study in the journal Biological ...
Breaking Biology News(10 mins):Five genes to predict colorectal cancer relapses 2Cape Cod saltmarsh recovery looks good, falls short 2Cape Cod saltmarsh recovery looks good, falls short 3
... Even moderate thyroid dysfunction during early pregnancy significantly increases ... universal screening in the first trimester, a new study ... Endocrine Society,s 94th Annual Meeting in Houston. "These ... studies that all pregnant women, irrespective of their risk ...
... Gallagher and his wife, Elizabeth, have made a $5 ... Family Professorships in Adult Stem Cell Research at the ... fund three new endowed professorships in adult and all ... Dame,s leadership in the field of stem cell research ...
... An elementary school science activity asks children who have each ... with string and tape to other "organisms" their assigned plant ... ecosystem web has been created, the teacher describes an event ... Other "organisms" that feel the tug then tug on their ...
Cached Biology News:Mild thyroid dysfunction in early pregnancy linked to serious complications 2Notre Dame establishes professorships in adult stem cell research 2Notre Dame establishes professorships in adult stem cell research 3Foundational concept of ecology tested by experiment 2Foundational concept of ecology tested by experiment 3Foundational concept of ecology tested by experiment 4
The Light Diagnostics Calicivirus Genotype 1&2 Typing OligoDetect assay is applicable for the qualitative detection of calicivirus RNA generated by an in-house validated in vitro nucleic acid amplifi...
X-Gal...
Recombinant Rat CINC-2 alpha, CF...
RABBIT ANTI SRC-RSV...
Biology Products: